5G Cloud-Enabled Telemedicine for Remote Management of Heart Failure Patients With Implantable Cardioverter-Defibrillators: A Multicenter Open-Label Randomized Controlled Trial.
Remote heart monitoring via 5G improved quality of life for patients with implanted defibrillators after one year.
This randomized controlled trial examined 5G Cloud-Enabled Telemedicine for Remote Management of Heart Failure Patients With Implantable Cardioverter-Defibrillators: A Multicenter Open-Label Randomized Controlled Trial. The PubMed abstract reports For secondary endpoints, the 5G-CTP group showed greater improvement in life quality at 12 months based on Minnesota Living with Heart Failure Questionnaire (p = 0012).
What the study was
- Study design
- Randomized controlled trial
- Population
- Human participants or patients described in the abstract
- Sample size
- 206
- Category
- Prevention
- Maturity
- Validated
- Journal
- MedComm
Why it surfaced
Randomized controlled trial with human evidence; score reflects novelty, clinical relevance, design quality, and population or unmet-need value under the v1.3 rubric.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.